Jad Adaimi

Company: Ultragenyx

Job title: Vice President, Global Regulatory Affairs

Bio:

Jad is an accomplished regulatory affairs leader that led regulatory efforts across multiple therapeutic areas, contributing to the advancement of breakthrough products from early development through approval and commercialization.

He currently serves as Vice President of Regulatory Affairs at Ultragenyx, where he plays a pivotal role in shaping regulatory strategy for innovative treatments, including gene therapies targeting rare conditions. His work in the rare disease space has included several gene therapy programs, with a deep understanding of complex global regulatory environments.

Known for his strategic vision and collaborative approach, he is passionate about advancing transformative therapies and navigating the evolving regulatory landscape to bring meaningful treatments to patients with high unmet needs.

Seminars:

Live Insights Lab: Navigating FDA & CBER Leadership Changes Impacting CGT Development 3:45 pm

Join this interactive session to reflect on a year of FDA changes, explore their impact, and collaborate in small groups to craft key questions and discussion points, then watch them come to life in a dynamic panel conversation. Shifts in trial design expectations: from single-arm studies to randomized controlled trials and innovative alternatives Evolving CMC…Read more

day: Conference Day One